Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the EBITDA margin high or low?
The EBITDA margin of -883.91% is 77% above its 5-year average of -3803.47%, near the high end of its 5-year range (-227029.79%–17050.47%).
76.51% above its 12-month average of -3763.31%.
Reported quarterly EBITDA margin; no daily interpolation. Q4 FY2025 (2025-12-31): 349.37%.
EBITDA MARGIN
-883.91%
EBITDA MARGIN AVG TTM
-3763.31%
EBITDA MARGIN AVG 3Y
-37682.70%
EBITDA MARGIN AVG 5Y
-3803.47%
EBITDA MARGIN AVG 10Y
-3404.48%
EBITDA MARGIN AVG 15Y
-4134.56%
EBITDA MARGIN AVG 20Y
-6267.37%
CURRENT VS TTM AVG
+76.51%
CURRENT VS 3Y AVG
+97.65%
CURRENT VS 5Y AVG
+76.76%
CURRENT VS 10Y AVG
+74.04%
CURRENT VS 15Y AVG
+78.62%
CURRENT VS 20Y AVG
+85.90%
ABVC BioPharma, Inc.
Market Cap
$25.48M
EBITDA Margin
-883.91%
TTM Avg
-3763.31%
3Y Avg
-37682.70%
5Y Avg
-3803.47%
Market Cap
$24.44M
EBITDA Margin
-710238.40%
TTM Avg
-369696.29%
3Y Avg
-185511.92%
5Y Avg
-193923.76%
Market Cap
$28.43M
EBITDA Margin
-40038.95%
TTM Avg
-34141.60%
3Y Avg
-20873.74%
5Y Avg
-16727.01%
Market Cap
$21.90M
EBITDA Margin
-7.62%
TTM Avg
-5.66%
3Y Avg
-2.78%
5Y Avg
-31.67%
Market Cap
$30.65M
EBITDA Margin
-10097.04%
TTM Avg
-6618.17%
3Y Avg
-8743.58%
5Y Avg
-8072.84%
Market Cap
$31.36M
EBITDA Margin
-108.41%
TTM Avg
-31.49%
3Y Avg
5.24%
5Y Avg
21.14%
Market Cap
$18.82M
EBITDA Margin
-23.24%
TTM Avg
-24.75%
3Y Avg
-25.93%
5Y Avg
-17.56%
| NAME | MARKET CAP | EBITDA MARGIN | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| ABVC BioPharma, Inc. (ABVC) | $25.48M | -883.91% | -3763.31% | -37682.70% | -3803.47% |
| Atossa Therapeutics, Inc. (ATOS)vs › | $24.44M | -710238.40% | -369696.29% | -185511.92% | -193923.76% |
| aTyr Pharma, Inc. (ATYR)vs › | $28.43M | -40038.95% | -34141.60% | -20873.74% | -16727.01% |
| Aytu BioPharma, Inc. (AYTU)vs › | $21.90M | -7.62% | -5.66% | -2.78% | -31.67% |
| Actuate Therapeutics Inc (ACTU)vs › | $20.93M | N/A | N/A | N/A | N/A |
| CervoMed Inc. (CRVO)vs › | $30.65M | -10097.04% | -6618.17% | -8743.58% | -8072.84% |
| Context Therapeutics Inc. (CNTX)vs › | $30.92M | N/A | N/A | N/A | N/A |
| Baird Medical Investment Holdings Limited (BDMD)vs › | $31.36M | -108.41% | -31.49% | 5.24% | 21.14% |
| Cosmos Health Inc. (COSM)vs › | $18.82M | -23.24% | -24.75% | -25.93% | -17.56% |
| Estrella Immunopharma, Inc. (ESLA)vs › | $18.77M | N/A | N/A | N/A | N/A |
Gross Margin
0.0%
EBITDA Margin
-883.9%
Operating Margin
0.0%
Net Margin
0.0%
Formula: EBITDA Margin = (EBITDA / Revenue) × 100
Why EBITDA Margin matters:
EBITDA Margin = EBITDA / Revenue
EBITDA margin measures operating profitability before interest, taxes, depreciation, and amortization as a percentage of revenue.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | EBITDA MARGIN |
|---|---|
| 2025-12-31 | 349.37% |
| 2024-12-31 | -7875.99% |
| 2024-09-30 | -50.34% |
| 2024-06-30 | -636.65% |
| 2024-03-31 | -227029.79% |
| 2023-12-31 | -90255.33% |
| 2023-09-30 | -13519.35% |
| 2023-06-30 | -35797.10% |
| 2023-03-31 | -1480.99% |
| 2022-12-31 | -530.83% |
| 2022-09-30 | -8775.65% |
| 2022-06-30 | -652.49% |
| 2022-03-31 | -24213.99% |
| 2021-12-31 | 17050.47% |
| 2021-09-30 | -1987.59% |
| 2021-06-30 | -6464.72% |
| 2021-03-31 | -474.94% |
| 2020-12-31 | -7788.35% |
| 2020-09-30 | -1108.61% |
| 2020-06-30 | -522.53% |
| 2020-03-31 | -1472.60% |
| 2019-12-31 | -1113.01% |
| 2019-09-30 | -556.99% |
| 2019-06-30 | -246.70% |
| 2019-03-31 | -337.65% |
| 2018-12-31 | -39573.05% |
| 2018-09-30 | -51635.34% |
| 2018-06-30 | -15892.88% |
| 2015-09-30 | -2806.36% |
| 2015-03-31 | -37.17% |
| 2013-03-31 | -1642.44% |
| 2012-12-31 | -1842.88% |
| 2012-06-30 | 1755.86% |
| 2012-03-31 | -8799.97% |
| 2011-12-15 | -21992.97% |
| 2011-03-31 | -44677.08% |
| 2010-12-31 | -14502.31% |
| 2010-09-30 | -10810.30% |
| 2010-05-21 | -11580.49% |
| 2010-02-08 | -7620.78% |
| 2009-12-31 | -14145.92% |
| 2009-03-31 | -7560.18% |
| 2008-12-31 | 2112.08% |
| 2008-09-30 | -503027.88% |
| 2008-06-30 | -32133.19% |
| 2008-03-31 | -14719.20% |
| 2007-12-31 | -13787.74% |
| 2007-09-30 | -12150.00% |
| 2007-06-30 | -5757.67% |
| 2006-09-30 | -13172.46% |
| 2005-03-31 | -156.15% |
| 2004-12-31 | -349.63% |
| 2004-09-30 | 37.98% |
| 2004-03-31 | -593.29% |
| 2003-09-30 | -200.00% |
| 2003-03-31 | 0.00% |
| 2002-12-31 | 0.00% |
| 2002-09-30 | -100.00% |
